Hikma and Guardant Health sign exclusive partnership agreement to bring transformative cancer diagnostic technology
2024-01-08
to the Middle East and North Africa Amman, Jordan Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive agreement with Guardant Health, Inc., a leading precision oncology company. Through the agreement, Hikma has the exclusive rights for commercialisation and marketing of Guardant Health’s portfolio of liquid and tissueContinue Reading